0407 Fin QTs
BioCentury & Getty Images


Venture rounds for Icosavax, Nucleix, Vizgen, Inscripta, Metagenomi and Volastra

Apr 8, 2021 | 12:15 AM GMT

Vaccine developer Icosavax Inc. raised $100 million in a series B round led by RA Capital Management. New

Read the full 384 word article

How to gain access

Continue reading with a
two-week free trial.